论文部分内容阅读
AIM:To show a new paradigm of simultaneously testing whether breast cancer therapies impact other causes of death.METHODS:MA.14 allocated 667 postmenopausal women to 5 years of tamoxifen 20 mg/daily±2 years of octreotide 90 mg,given by depot intramus